InvestorsObserver
Sign Up Login

NMRD Nemaura Medical Inc

$0.06 $0.00 (-5.00%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

NMRD Stock Analysis Overview

What this means: Nemaura Medical Inc (NMRD) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives NMRD a rank of 25. Our methodology considers analysis of the company's financial situation and how it has traded recently. NMRD rank of 25 means that it ranks below 75% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

NMRD Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

NMRD Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

NMRD Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

NMRD Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

NMRD Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

NMRD Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

NMRD Stock Analysis Overview

What this means: Nemaura Medical Inc (NMRD) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives NMRD a rank of 25. Our methodology considers analysis of the company's financial situation and how it has traded recently. NMRD rank of 25 means that it ranks below 75% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full NMRD report

NMRD Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

NMRD Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

NMRD Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

NMRD Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

NMRD Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

NMRD Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Nemaura Medical Inc (NMRD) Analyst Forecast

NMRD Price, Volume, Earnings, and Dividend Date

  • Last Price $0.06
  • Previous Close $0.06
  • Change $0.00
  • Open $0.05
  • Volume 252,056
  • Avg. Volume (100-day) 89,294
  • Market Cap 1,647,266
  • Days Range 0.0333 - 0.0635
  • 52-week Range 0.03 - 1.25
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 02/11/24
  • Sector Healthcare
  • Industry Medical Devices
  • Avg. Analyst Rec. Premium
  • Beta -9.345
  • PEG Ratio —

Nemaura Medical Inc (NMRD) Company Description

Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter with an app displaying glucose readings at five minute intervals for periods up to 24 hours.

Nemaura Medical Inc (NMRD) Stock Chart

View Interactive NMRD chart

My Watchlists

Top Stocks in Medical Devices